Professors Ziv Shulman and Irit Sagi, the scientists behind the study, discovered naturally-produced antibodies which target an enzyme known as MMP14 (MT1-MMP) in tumors. While outside of a tumor, the enzyme normally assists the body with repairing tissue, when found in a cancerous environment, MMP14 helps the malignancy spread. Read more . . . .
A new study published this week in Cell scientific journal said that while immunotherapies for cancer rely on the patient’s immune system, they still “fall short of tapping into the entire arsenal of the body’s natural defenses.”